SCN2A and SCN8A encephalopathies both are associated with gain-of-function mutations and respond well to sodium channel blockers.15,16 Here, we show that SCN1A also contributes to the severe early infantile–onset developmental encephalopathies, but we do not yet understand why this recurrent mutation causes this profound phenotype. This evidence concerns the gene SCN1A and Encephalopathy.